1999
Comparative Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Antagonism on Plasma Fibrinolytic Balance in Humans
Brown N, Agirbasli M, Vaughan D. Comparative Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Antagonism on Plasma Fibrinolytic Balance in Humans. Hypertension 1999, 34: 285-290. PMID: 10454455, DOI: 10.1161/01.hyp.34.2.285.Peer-Reviewed Original ResearchMeSH KeywordsAdultAldosteroneAngiotensin IIAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBlood PressureData Interpretation, StatisticalDiet, Sodium-RestrictedFemaleFibrinolysisHeart RateHumansIsoquinolinesLosartanMalePlasminogen Activator Inhibitor 1QuinaprilReninRenin-Angiotensin SystemTetrahydroisoquinolinesTissue Plasminogen ActivatorConceptsPlasminogen activator inhibitor-1PAI-1 antigenTissue plasminogen activatorACE inhibitorsFibrinolytic balanceAldosterone systemAngiotensin II type 1 receptor antagonismAngiotensin II type 1 receptor antagonistAngiotensin-Converting Enzyme InhibitionType 1 receptor antagonistPlasma PAI-1 antigenPAI-1 antigen concentrationsAntigen concentrationEquivalent hypotensive dosesPlasma fibrinolytic balancePlasma renin activityAngiotensin II formationLow salt intakePAI-1 activityClass of drugsTPA antigen concentrationsActivator inhibitor-1Enzyme inhibitionLosartan treatmentQuinapril treatment
1998
A Model for Improving Medication Use in Home Health Care Patients
Brown N, Griffin M, Ray W, Meredith S, Beers M, Marren J, Robles M, Stergachis A, Wood A, Avorn J. A Model for Improving Medication Use in Home Health Care Patients. Journal Of The American Pharmacists Association 1998, 38: 696-702. PMID: 9861787, DOI: 10.1016/s1086-5802(16)30390-4.Peer-Reviewed Original ResearchConceptsHome health nursesHome health careMedication useMedication problemsHealth nursesCare settingsHome health care patientsPotential medication problemsSuboptimal medication useHome health nursingHome health care settingHealth careHealth care patientsSpecific adverse effectsClass of drugsHealth care settingsHome care settingHealth services researchElderly patientsCare patientsClinical signsClinical pharmacologyHealth nursingExpert panel reviewDrug use